Ibrance 75 MG capsule 21S
Ended Awarded Last action
- Contract number
- SPE2DR26FL9KZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,561
Award facts
- Contract value 100% obligated
- $8,561.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $8,561.41 to AmerisourceBergen Drug Corp for Ibrance 75 mg capsules (21-count) on November 26, 2025, with a completion date of December 18, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Ibrance (palbociclib) is a specialty oncology medication used in cancer treatment, reflecting the contractor's role in delivering critical therapeutic drugs across multiple medical domains to federal health systems including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26FL9KZ?
SPE2DR26FL9KZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26FL9KZ worth?
The government has obligated $8,561 on SPE2DR26FL9KZ.
Is contract SPE2DR26FL9KZ an order under another contract?
Yes. SPE2DR26FL9KZ is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FL9KZ competed?
The extent of competition for SPE2DR26FL9KZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award